Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts Inc (NQ: TMCI )

6.315 -0.065 (-1.02%)
Streaming Delayed Price Updated: 2:13 PM EDT, Aug 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Treace Medical Concepts Inc

< Previous 1 2 Next >
Treace Medical Concepts Reports Second Quarter 2024 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Second Quarter 2024 Financial Results on August 6, 2024
From Treace Medical Concepts, Inc.
Via GlobeNewswire
3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
Insiders are buying the dips in these three stocks, which suggests a rebound is coming. There are reasons the market dipped, but the sell-offs are overdone. 
Via MarketBeat
Topics Initial Public Offering
Exposures Securities Market
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI)
From Kirby McInerney LLP
Via Business Wire
Treace to Present at Bank of America Health Care Conference
Wednesday, May 15, 2024, at 2:20 pm Pacific Time 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces First Annual National Bunion Day
Focus on Foot Health Issue Affecting Millions of People Includes Outreach and Education Efforts to Build Awareness, Reduce Stigma and Correct Misconceptions About This Common Bone Deformity 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report First Quarter 2024 Financial Results
Company to Host Conference Call on Tuesday, May 7, 2024 at 4:30 pm ET 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
Company to Host Conference Call on Tuesday, February 27, 2024 at 4:30 pm ET 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
Company Previews New SpeedPlate™ Configurations, Announces Full Commercial Release of its Micro-Lapiplasty™ System and Limited Clinical Release of its Mini-Adductoplasty™ System and RedPoint™... 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
Company to Present at J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 3:45 pm Pacific Time 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
Tuesday, January 9, 2024, at 3:45 pm Pacific Time 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Reports Third Quarter 2023 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Present at Stifel 2023 Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Third Quarter 2023 Financial Results
Company to Host Conference Call on Thursday, November 9, 2023 at 4:30 pm ET 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Participation in the 21st Annual Morgan Stanley Global Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Reports Second Quarter 2023 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Participation in the UBS Medtech, Tools and Genomics Summit 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Second Quarter 2023 Financial Results on August 8, 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Appoints Julie Dewey as Chief Communications and Investor Relations Officer
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Completes Acquisition of Technology Enabling Patient Specific Instrumentation and Reports on Clinical Cases Using PSI with the Lapiplasty® System
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts to Acquire Technology Enabling Patient Specific Instrumentation for Foot and Ankle Surgeries
From Treace Medical Concepts, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.